Australia markets closed

Jazz Pharmaceuticals plc (JAZZ)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
108.32-1.35 (-1.23%)
At close: 04:00PM EDT
108.32 0.00 (0.00%)
After hours: 04:20PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 6.84B
Enterprise value 11.01B
Trailing P/E 17.99
Forward P/E 5.89
PEG ratio (5-yr expected) 0.83
Price/sales (ttm)2.06
Price/book (mrq)1.83
Enterprise value/revenue 2.87
Enterprise value/EBITDA 8.98

Trading information

Stock price history

Beta (5Y monthly) 0.61
52-week change 3-20.49%
S&P500 52-week change 325.01%
52-week high 3146.70
52-week low 3106.61
50-day moving average 3119.24
200-day moving average 3125.77

Share statistics

Avg vol (3-month) 3610.17k
Avg vol (10-day) 3573.49k
Shares outstanding 562.35M
Implied shares outstanding 662.35M
Float 860.45M
% held by insiders 12.81%
% held by institutions 197.92%
Shares short (28 Mar 2024) 43.26M
Short ratio (28 Mar 2024) 43.98
Short % of float (28 Mar 2024) 46.04%
Short % of shares outstanding (28 Mar 2024) 45.23%
Shares short (prior month 29 Feb 2024) 42.39M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 10.82%
Operating margin (ttm)23.18%

Management effectiveness

Return on assets (ttm)4.56%
Return on equity (ttm)12.16%

Income statement

Revenue (ttm)3.83B
Revenue per share (ttm)60.58
Quarterly revenue growth (yoy)4.10%
Gross profit (ttm)N/A
EBITDA 1.45B
Net income avi to common (ttm)414.83M
Diluted EPS (ttm)6.10
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.63B
Total cash per share (mrq)26.15
Total debt (mrq)5.8B
Total debt/equity (mrq)155.21%
Current ratio (mrq)2.24
Book value per share (mrq)60.03

Cash flow statement

Operating cash flow (ttm)1.09B
Levered free cash flow (ttm)1.05B